Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
68.98
-2.71 (-3.78%)
At close: Oct 03, 2025, 3:59 PM
69.46
0.70%
Pre-market: Oct 06, 2025, 05:13 AM EDT
Halozyme Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 61.86M | 176.33M | 115.85M | 154.32M | 187.86M | 164.63M | 118.37M | 274.23M | 221.16M | 96.38M | 234.19M | 147.16M | 90.93M | 117.83M | 118.72M | 491.68M | 446.97M | 499.45M |
Short-Term Investments | 486.32M | 571.59M | 480.22M | 511.99M | 341.17M | 298.82M | 217.63M | 209.06M | 127.11M | 179.22M | 128.6M | 118.42M | 118.43M | 668.3M | 622.2M | 324.24M | 308.34M | 264.86M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 56.37M | 55.61M | 80.6M | 80.15M | 52.48M | 17.32M | 17.82M | 18.11M | 18.41M | 25.74M | 26.8M | 26.28M | 26.78M | 22.54M | 13.91M | 16.05M | 15.98M | 14.5M |
Receivables | 316.34M | 304.62M | 308.45M | 285.74M | 214.52M | 195.9M | 234.21M | 217.32M | 246.18M | 194.88M | 231.07M | 233.3M | 189.37M | 113.76M | 90.97M | 112.1M | 153.2M | 88.39M |
Inventory | 181.5M | 164.87M | 141.86M | 131.41M | 159.31M | 168.54M | 127.6M | 128.92M | 132.41M | 107.52M | 100.12M | 103.28M | 97.61M | 47.76M | 53.91M | 55.98M | 58.55M | 58.34M |
Other Current Assets | 76.65M | 44.62M | 38.95M | 43.52M | 84.93M | 45.69M | 48.61M | 49.48M | 38.88M | 37.01M | 45.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 1.12B | 1.26B | 1.09B | 1.13B | 987.8M | 873.58M | 746.42M | 879.01M | 765.75M | 615.02M | 739.01M | 653.2M | 541.94M | 988.69M | 926.29M | 1.02B | 999.75M | 941.72M |
Property-Plant & Equipment | 71.52M | 72.82M | 75.03M | 74.49M | 75M | 78.07M | 74.94M | 74.67M | 74.56M | 77.96M | 75.57M | 36.67M | 37.09M | 8.51M | 8.79M | 9.59M | 10.13M | 10.37M |
Goodwill & Intangibles | 783.13M | 800.89M | 818.65M | 836.41M | 854.17M | 871.94M | 889.7M | 907.46M | 927.8M | 945.04M | 955.7M | 1.15B | 1.18B | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 931.23M | 934.5M | 978.14M | 991.05M | 981.66M | 967.94M | 986.85M | 1.01B | 1.04B | 1.08B | 1.1B | 1.21B | 1.24B | 173.56M | 178.14M | 168.12M | 26.11M | 24.86M |
Total Assets | 2.05B | 2.2B | 2.06B | 2.12B | 1.97B | 1.84B | 1.73B | 1.89B | 1.81B | 1.7B | 1.84B | 1.86B | 1.78B | 1.16B | 1.1B | 1.19B | 1.03B | 966.58M |
Account Payables | 18.69M | 20.07M | 10.25M | 12.4M | 15.43M | 13.32M | 11.82M | 19.32M | 10.12M | 8.7M | 17.69M | 18.17M | 12.23M | 1.27M | 1.54M | 3.32M | 4.56M | 535K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 667K | 842K | 3.25M | 3.25M | 3.59M | 4.13M | 1.75M | 1.75M | 2.25M | 1.25M | 1.75M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.33M | 13.31M | 99.05M | 89.55M | 89.42M | 89.25M | 89.17M | 89.04M |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 134.28M | 150.38M | 139.1M | 108.81M | 133.36M | 131.64M | 112.49M | 115.19M | 116.39M | 91.92M | 130.79M | 109.38M | 199.51M | 111.69M | 117.15M | 113.15M | 114.25M | 107.42M |
Long-Term Debt | 1.51B | 1.51B | 1.51B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.49B | 1.49B | 1.49B | 1.15B | 788.1M | 787.25M | 786.45M | 785.57M | 784.73M |
Other Long-Term Liabilities | 77.77M | 56.44M | 54.76M | 40.41M | 30.51M | 31.2M | 37.72M | 28.42M | 44.76M | 45.05M | 45.91M | 135.19M | 135.55M | 171K | 544K | 1.61M | 2.27M | 2.81M |
Total Long-Term Liabilities | 1.59B | 1.56B | 1.56B | 1.56B | 1.55B | 1.53B | 1.54B | 1.53B | 1.54B | 1.54B | 1.54B | 1.66B | 1.29B | 790.3M | 790.33M | 790.59M | 791.86M | 791.57M |
Total Liabilities | 1.72B | 1.71B | 1.7B | 1.67B | 1.68B | 1.66B | 1.65B | 1.64B | 1.66B | 1.63B | 1.67B | 1.77B | 1.49B | 901.99M | 907.48M | 903.75M | 906.12M | 898.99M |
Total Debt | 1.51B | 1.51B | 1.51B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.49B | 1.51B | 1.5B | 1.25B | 877.64M | 876.67M | 875.71M | 874.74M | 873.77M |
Book Value | 332.75M | 482.27M | 363.82M | 452.7M | 289.42M | 177.81M | 83.81M | 249.18M | 151.03M | 65.85M | 169.8M | 96.99M | 293.17M | 260.26M | 196.95M | 281.67M | 119.75M | 67.59M |
Book Value Per Share | 2.74 | 3.91 | 2.88 | 3.57 | 2.28 | 1.40 | 0.65 | 1.89 | 1.15 | 0.49 | 1.26 | 0.71 | 2.13 | 1.89 | 1.40 | 1.98 | 0.84 | 0.49 |
Common Stock | 118K | 123K | 123K | 127K | 127K | 127K | 127K | 132K | 132K | 132K | 135K | 135K | 138K | 138K | 138K | 141K | 142K | 143K |
Retained Earnings | 361.03M | 477.96M | 359.87M | 397.63M | 260.62M | 167.37M | 90.55M | 222.28M | 140.45M | 65.69M | 143.22M | 85.52M | 23.88M | 1.2M | -58.91M | -125.68M | -342.27M | -433.73M |
Comprehensive Income | -28.4M | -3.41M | 3.83M | -6.94M | -2.07M | -1.49M | -9.28M | 1.23M | -1.61M | 24K | -922K | -1.84M | -2.02M | -2.79M | -620K | -14K | -24K | -9K |
Shareholders Equity | 332.75M | 482.27M | 363.82M | 452.7M | 289.42M | 177.81M | 83.81M | 249.18M | 151.03M | 65.85M | 169.8M | 96.99M | 293.17M | 260.26M | 196.95M | 281.67M | 119.75M | 67.59M |
Total Investments | 486.32M | 571.59M | 480.22M | 511.99M | 341.17M | 298.82M | 217.63M | 209.06M | 127.11M | 179.22M | 128.6M | 118.42M | 118.43M | 668.3M | 622.2M | 324.24M | 308.34M | 264.86M |